924 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
4 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
5 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
6 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
7 Not yet recruiting Trial of Topotecan With VX-970, an ATR Kinase Inhibitor, in Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small -Cell Lung;   Ovarian Neoplasms;   Small Cell Lung Carcinoma;   Uterine Cervical Neoplasms;   Carcinoma, Neuroendocrine
Interventions: Drug: Topotecan;   Drug: VX-970
8 Recruiting Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Atezolizumab (MPDL3280A);   Other: Best Supportive Care (BSC)
9 Not yet recruiting Study Evaluating the Efficacy, Safety and Pharmacokinetics in Patient With T790M-positive Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: HM61713 tablet
10 Not yet recruiting Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
11 Not yet recruiting Efficacy Study of Nivolumab or Chemotherapy in Subjects With Relapsed Small-cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: Nivolumab;   Drug: Topotecan;   Drug: Amrubicin
12 Not yet recruiting Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC
Condition: Non-small Cell Lung Cancer
Intervention: Procedure: segmentectomy
13 Not yet recruiting Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Bone Metastasis
Interventions: Drug: Zoledronic acid;   Radiation: Radiotherapy
14 Not yet recruiting MPDL3280A-treatment-IST-UMCG
Conditions: Bladder Cancer;   Non Small Cell Lung Cancer;   Breast Cancer
Intervention: Drug: MPDL3280A
15 Not yet recruiting An Open-Label, Trial of Nivolumab and Nivolumab Plus Ipilimumab Versus Platinum Doublet Chemotherapy in Subjects With Stage IV Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Nivolumab;   Drug: Ipilimumab;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Pemetrexed
16 Recruiting Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation
Condition: Small Cell Lung Cancer Recurrent
Intervention: Drug: Temozolomide
17 Not yet recruiting Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
18 Available Expanded Access Program With Nivolumab Monotherapy for Treatment of Advanced/Metastatic SqNSCLC After One Prior Systemic Regimen
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Nivolumab
19 Not yet recruiting Safety Study of MGA271 in Combination With Pembrolizumab in Refractory Cancer
Conditions: Melanoma;   Head and Neck Cancer;   Non Small Cell Lung Cancer
Interventions: Biological: MGA271;   Biological: Pembrolizumab
20 Not yet recruiting Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC
Condition: Non-small Cell Lung Cancer
Interventions: Radiation: Personalized dose redistribution;   Radiation: No personalized dose redistribution

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years